アルブミン市場：供給源、タイプ、用途、エンドユーザー別-2024-2030年の世界予測

アルブミン市場規模は2023年に65億3,000万米ドルと推計され、2024年には69億4,000万米ドルに達し、CAGR 6.61％で2030年には102億3,000万米ドルに達すると予測されています。

アルブミンは、ヒト血漿中の総タンパク質の約50％～60％を占める複雑で汎用性の高いタンパク質です。主に肝臓で合成され、浸透圧の維持、様々な分子の結合・輸送、抗酸化剤としての働きなど、生理機能に不可欠な役割を担っています。アルブミンの重要性は、全体的な健康と幸福への多面的な貢献にあり、個人の疾病リスクと臨床状態を評価するための重要なバイオマーカーとなっています。火傷の治療や、患者が適切な健康機能を維持するためにHSAの定期的な供給を必要とする肝疾患の有病率の上昇に伴い、アルブミンの臨床現場での使用量が増加しており、アルブミンの使用は世界中で加速しています。しかし、プールされたヒト血漿から供給されるHSA製品の汚染や感染因子の伝播に関連するリスクは、アルブミンの使用に影響を与えています。また、各地域における製品認可のための厳しい規制ガイドラインもアルブミンの商業化に影響を与えています。市場開拓者は、より低コストで高品質のアルブミン製品を生産できる植物ベースの発現システムや微生物発酵プロセスなど、革新的な生産方法を探求する研究開発に投資しています。遺伝子組換え技術による組換えヒトアルブミン（rHA）の生産を可能にするバイオテクノロジーの進歩により、新たな機会が生まれています。

出典特定の治療目的での持続可能性の向上による、植物由来のアルブミンへの消費者のシフト。

血液中の重要なタンパク質であるアルブミンは、体液バランスの維持、ホルモン、脂肪酸、薬物の運搬に不可欠な役割を果たしています。アルブミンの一次情報は、動物由来と植物由来の2種類です。動物由来のアルブミンはウシ血清（BSA）、ヒト血漿（HSA）、ovアルブミンから得られます。ウシ血清アルブミン（BSA）は、診断試薬、ワクチン、細胞培養培地など様々な用途に不可欠な成分です。BSAは手頃な価格で入手しやすいため、診断や研究に広く利用されています。ヒト血清アルブミン（HSA）は、ヒトとの生体適合性が高いため、ドラッグデリバリーシステムや容量拡張療法などの特定の臨床場面で好まれます。HSAは、火傷治療や心肺バイパス手術のような医療緊急時に使用されます。近年、植物由来の代替物質は、環境への影響や潜在的なアレルゲンリスクを低減するため、持続可能な選択肢として浮上しています。米タンパク質や大豆タンパク質を含む植物由来のアルブミンは、飲食品、医薬品、化粧品などの用途において、動物由来のアルブミンの代替品として人気を集めています。比較的、動物由来のアルブミンは、病気伝染のリスクはあるもの、医療への応用が確立されています。対照的に、植物由来のアルブミンは、汚染リスクを最小限に抑えた持続可能性を提供しますが、特定の治療目的への適合性に欠ける可能性があります。しかし、動物性または植物性アルブミンのどちらを選ぶかという消費者の動向は、用途目的、純度要件、持続可能性への懸念、動物性タンパク質に関連する潜在的リスクなどの要因に左右されます。

タイプ組換えDNA技術を促進するため、合成タンパク質としての組換え型アルブミンの研究開発に重点を置いた。

非組み換え型アルブミンは天然由来で、主にヒトとウシの血清に由来します。タンパク質や酵素を安定化させる性質があるため、医薬製剤、診断薬、細胞培養培地、医療機器などに広く使用されています。非組換え型アルブミンの必要性に基づく選好は、血液分画過程の製品別として大量に入手可能であることから生じる。組換えアルブミンは酵母や哺乳類細胞などの遺伝子操作発現系を用いて生産されます。非組み換え型アルブミンに比べ、病原体混入のリスクがなく、より安定した持続可能な供給が可能です。リコンビナントアルブミンは主にドラッグデリバリーシステム、ワクチン、細胞治療、再生医療に使用されています。リコンビナントアルブミンが好まれる背景には、感染症を媒介する可能性のあるヒトや動物由来の成分を含まないという安全性があります。

応用ワクチン製造やドラッグデリバリー用途への注目の高まり

アルブミンは、その優れた水結合特性により、肌の保湿性と弾力性を高めるため、化粧品原料として広く使用されています。バイオテクノロジー業界では、アルブミンは細胞の成長と増殖をサポートする培養液の必須成分として役立っています。アルブミンのドラッグデリバリーへの応用は、様々な条件下で安定性を保ちながら、様々な分子を結合させる能力を利用しています。アルブミンは、乳化や起泡などの機能性により、食品素材として様々な製品に使用されています。アルブミンに基づく治療薬は、低アルブミン血症や火傷などの治療薬に採用されています。さらに、ワクチン製造業者は、アルブミンを安定剤や防腐剤として使用し、保管や輸送中のワクチンの安定性を高めています。

エンドユーザー：病院や血液バンクにおけるアルブミンの広範なエンドユーザー

アルブミンの主なエンドユーザーは、病院・診療所、製薬・バイオテクノロジー企業、学術研究機関、血液銀行などの1次産業に分類されます。これらの施設では、アルブミン製品を、薬剤の調合、診断、ワクチン製造、臨床栄養サポート、細胞培養成長培地の補充、血液量の拡大など様々な目的で利用しています。病院や診療所では、アルブミンは、重篤な病気や怪我によって引き起こされる低アルブミン血症（血液中のアルブミン濃度が低いことを特徴とする状態）を患う患者の治療にしばしば使用されます。また、出血を伴う手術や外傷の際の体液蘇生にも利用されています。近年、アルブミンは、経口摂取が困難な患者に必要なタンパク質を供給する非経口栄養剤の成分としても人気を博しています。さらに、血液バンクでは、輸血を受ける患者や外傷、手術、その他の疾患により重度の出血を伴う患者の血液量を増加させるための血漿増量剤として利用されています。アルブミンソリューションは、浸透圧を維持し、血行動態パラメータを安定させ、そのような危機的状況下で全体的な循環機能を改善するのに役立ちます。

地域別インサイト

南北アメリカのアルブミン市場は、先進的なアルブミン製剤を開発するための研究と技術に多額の投資を行っている製薬会社による投資によって発展しています。米国の食品医薬品局（FDA）などの規制機関は、アルブミンの安全基準を保証するために厳格な品質管理を実施しています。FDAも近年、特定のアルブミン製品について認可を与えています。米国とカナダでは、アルブミン供給のためのヒト血漿提供への依存を減らすために、組換えHSA生産などの技術的進歩が調査しています。アジアのアルブミン市場は、肝疾患治療、手術、集中治療サポートなどの治療目的で血漿由来製品を必要とする新興国のヘルスケア支出の増加と医療インフラの改善により、急速に拡大しています。欧州は、確立された消費基盤と強固な製造能力を持ち、世界のアルブミン市場に貢献する可能性があります。欧州におけるアルブミンの使用は、主に敗血症管理、容量補充療法、治療的血漿交換処置などのクリティカルケア用途に集中しています。欧州医薬品庁（EMA）は、欧州連合（EU）内でのアルブミンの製造と流通を規制しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアルブミン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アルブミン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.アルブミン市場の市場規模および予測は？

2.アルブミン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.アルブミン市場の技術動向と規制枠組みは？

4.アルブミン市場における主要ベンダーの市場シェアは？

5.アルブミン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の発生率と術後手術部位感染の予測因子としてのアルブミンの使用
    • 食品・化粧品原料としてのアルブミンの利用が急増
  • 抑制要因
    • アルブミンが感染を引き起こす可能性
  • 機会
    • アルブミンナノ粒子に関する進行中の調査活動
    • アルブミン生産・精製方法の進歩
  • 課題
    • アルブミン製造および品質管理に関連する厳格な規制
• 市場セグメンテーション分析
  • 出典：特定の治療目的における持続可能性の向上により、消費者は植物由来のアルブミンへとシフトしています。
  • タイプ：組み換えDNA技術を促進するための合成タンパク質としての組み換えアルブミンの研究開発の強化
  • アプリケーション：ワクチン製造とドラッグデリバリーアプリケーションへの注目の高まり
  • エンドユーザー：病院や血液銀行におけるアルブミンの広範なエンドユーザー
• 市場動向分析
  • 医療技術の進歩は南北南北アメリカ全体での強力な投資によって補完されている
  • APAC地域でアルブミン製品を監視するための安全規制の利用可能性と相まって生産を拡大
  • EMEA地域における重要な調査活動と政府の規制枠組み。
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 アルブミン市場：ソース別

• 動物由来
• 植物由来

第7章 アルブミン市場：タイプ別

• 非組み換え
• 組み換え

第8章 アルブミン市場：用途別

• 化粧品原料
• 文化メディア
• ドラッグデリバリー
• 食品成分
• 治療的
• ワクチンの成分

第9章 アルブミン市場：エンドユーザー別

• 製薬・バイオテクノロジー
• 調査機関

第10章 南北アメリカのアルブミン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のアルブミン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのアルブミン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • グリフォルス、非代償性肝硬変患者に対する長期アルブテイン（アルブミンヒト注射剤）療法の第3相試験の登録を完了
  • ケドリオンの世界ポートフォリオが中国に拡大し、人材供給を開始
  • GCバイオファーマ、ブラジルで血液製剤の9,000万米ドル契約を締結
  • Albumedix、細胞・遺伝子治療カタパルトと提携契約を締結
  • アルブメディックスとヴァルネバは、新たに承認された不活化COVID-19ワクチンを含む協力関係を拡大
  • アメリカン・リージェント社、注射用懸濁液（アルブミン結合型）用パクリタキセルタンパク質結合粒子を発売
  • SKプラズマ、インドネシアに2億5,000万米ドルの血液製品工場を建設へ
  • グリフォルス、拡張中のダブリン拠点に新アルブミン工場を開設
  • サルトリウスがアルブメディクスを買収：組み換えに基づく先進的治療法のプレーヤーアルブミン
  • タイバン・バイオロジック・グループ、3億米ドルの資本調達を確保

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ALBUMIN MARKET RESEARCH PROCESS
• FIGURE 2. ALBUMIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ALBUMIN MARKET DYNAMICS
• FIGURE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. ALBUMIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. ALBUMIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ALBUMIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ALBUMIN MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 79. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 80. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 81. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 82. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 83. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. CANADA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 88. CANADA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 91. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 92. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 93. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 94. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 95. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 96. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 125. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 126. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 134. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 135. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 136. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 137. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. CHINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 142. CHINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 143. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 144. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 145. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 146. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 147. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 148. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 149. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. INDIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 152. INDIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 155. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 156. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 162. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 165. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 166. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 167. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 168. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 169. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 172. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 175. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 176. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 177. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 182. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 183. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 184. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 185. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 186. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 187. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 192. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 193. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 194. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 195. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 196. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 197. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 198. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 199. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 202. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 204. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 206. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 212. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 213. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 214. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 215. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 216. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 217. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 222. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 223. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 224. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 225. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 226. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 227. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 228. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 229. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 232. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 233. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 234. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 235. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 236. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 237. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 238. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 239. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 242. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 255. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 256. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 257. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 258. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 259. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 264. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 265. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 266. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 267. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 268. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 269. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 270. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 271. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 274. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 275. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 276. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 277. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 278. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 279. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 284. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 285. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 286. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 287. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 288. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 289. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 290. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 291. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 292. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 293. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 294. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 295. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 296. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 297. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 298. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 299. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 300. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 301. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 302. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 303. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 304. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 305. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 306. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 307. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 308. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 309. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 310. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 311. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 312. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 313. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 314. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 315. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 316. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 317. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 318. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 319. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 320. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 321. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 322. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 323. ITALY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 324. ITALY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 325. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 326. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 327. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 328. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 329. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 330. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 331. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 332. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 333. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 334. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 335. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 336. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 337. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 338. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 339. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 340. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 341. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 342. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 343. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 344. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 345. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 346. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 347. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 348. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 349. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 350. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 351. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 352. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 353. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 354. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 355. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 356. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 357. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 358. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 359. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 360. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 361. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 362. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 363. POLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 364. POLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 365. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 366. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 367. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 368. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 369. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 370. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 371. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 372. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 373. QATAR ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 374. QATAR ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 375. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 376. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 377. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 378. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 379. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 380. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 381. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 382. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 383. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 384. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 385. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 386. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 387. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 388. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 389. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 390. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 391. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 392. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 393. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 394. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 395. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 396. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 397. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 398. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 399. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 400. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 401. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 402. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 403. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 404. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 405. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 406. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 407. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
• TABLE 408. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
• TABLE 409. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 410. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 411. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 412. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)

TA

[192 Pages Report] The Albumin Market size was estimated at USD 6.53 billion in 2023 and expected to reach USD 6.94 billion in 2024, at a CAGR 6.61% to reach USD 10.23 billion by 2030.

Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. It is synthesized predominantly by the liver and plays an essential role in physiological functions, such as maintaining osmotic pressure, binding and transporting various molecules, and acting as an antioxidant. Albumin's importance lies in its multifaceted contributions to overall health and well-being, making it a significant biomarker for assessing an individual's disease risk and clinical status. The growing usage of albumin in clinical settings for the treatment of burns and the rising prevalence of liver diseases where patients require a regular supply of HSA to maintain proper health functions has accelerated the use of albumin worldwide. However, risks associated with contamination and transmission of infectious agents in HSA products sourced from pooled human plasma donations impact albumin usage. Stringent regulatory guidelines for product approvals in different regions also affect the commercialization of albumin. Market players are investing in research and development initiatives that explore innovative production methods, such as plant-based expression systems or microbial fermentation processes capable of yielding high-quality albumin products at lower costs. New opportunities are emerging with the evolution of biotechnological advancements that enable the production of recombinant human albumins (rHA) through genetic engineering techniques.

Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.

Albumin, an important protein in the blood, plays essential role in maintaining fluid balance and transporting hormones, fatty acids, and drugs. The two primary albumin sources are animal-based and plant-based. Animal-derived albumin is obtained from bovine serum (BSA), human plasma (HSA), and ovalbumin. Bovine serum albumin (BSA) is a vital ingredient in various applications, such as diagnostic reagents, vaccines, and cell culture media. BSA is widely utilized in diagnostics and research due to its affordability and accessibility. Human serum albumin (HSA) is preferred for certain clinical situations, such as drug delivery systems or volume expansion therapies, due to its biocompatibility with humans. HSA is used in medical emergencies such as burns treatment and cardiopulmonary bypass surgery. In recent years, plant-based alternatives have emerged as a sustainable option for albumin production due to their reduced environmental impact and potential allergen risks. Plant-derived albumins, including rice and soy protein, are gaining popularity as alternatives to animal-derived counterparts for applications in food & beverage production, pharmaceuticals, and cosmetics. Comparatively, animal-derived albumins have established medical applications, although they pose a risk of disease transmission. In contrast, plant-based albumins offer sustainability with minimal contamination risk but may lack compatibility for specific therapeutic purposes. However, consumer trends to preferences to choose products between animal or plant-based albumins depend on factors such as application purpose, purity requirements, sustainability concerns, and potential risks associated with animal proteins.

Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology

Non-recombinant albumin is derived from natural sources, primarily human and bovine serum. It is widely used in pharmaceutical formulations, diagnostics, cell culture media, and medical devices due to its stabilizing properties for proteins and enzymes. The need-based preference for non-recombinant albumin arises from its availability in large quantities as a byproduct of blood fractionation processes. Recombinant albumin is produced using genetically engineered expression systems such as yeast and mammalian cells. It eliminates the risk of contamination with pathogens and offers a more consistent and sustainable supply compared to non-recombinant albumin. Recombinant albumin is mainly used in drug delivery systems, vaccines, cell therapy applications, and regenerative medicine. The preference for recombinant albumin is driven by its safety profile, as it is free from human or animal-derived components which may carry potential risks of transmitting infectious agents.

Application: Rising focus on vaccine manufacturing and drug delivery applications

Albumin is widely used as a cosmetic ingredient due to its excellent water-binding properties, enhancing skin hydration and elasticity. In the biotechnology industry, albumin serves as an essential component of culture media to support cell growth and proliferation. Albumin's drug delivery application capitalizes on its ability to bind various molecules while maintaining stability in different conditions. Albumin is employed in various products as a food ingredient due to its functional properties, such as emulsification and foaming. Albumin-based therapeutics are employed in treatments for conditions such as hypoalbuminemia and burns. Moreover, vaccine manufacturers use albumins as stabilizers or preservatives to enhance vaccine stability during storage and transportation.

End-User: Extensive end-users of the albumin in hospitals and blood banks

The major end-users of albumin can be categorized into primary sectors including, hospitals & clinics, pharmaceutical & biotechnology companies, academic research institutes, and blood banks. These establishments utilize albumin products for various purposes such as drug formulation, diagnostics, vaccine manufacturing, clinical nutrition support, cell culture growth media supplementation, and blood volume expansion. In hospitals & clinics Albumin is often employed to treat patients suffering from hypoalbuminemia - a condition characterized by low levels of albumin in the blood - caused by critical illness or injury. Additionally, it is utilized for fluid resuscitation during surgeries or trauma cases where blood loss has occurred. In recent years, albumin has also gained popularity as a component of parenteral nutrition formulas providing essential proteins needed for patients who are unable to consume food orally. Moreover, blood banks utilize it as a plasma expander to increase blood volume in patients undergoing blood transfusion or those with severe blood loss due to trauma, surgery, or other conditions. Albumin solutions can help maintain osmotic pressure, stabilize hemodynamic parameters, and improve overall circulatory function during such critical situations.

Regional Insights

The Americas albumin market is advancing, driven by investments by pharmaceutical companies investing heavily in research and technology to develop advanced albumin formulations. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. enforce strict quality control measures to assure safety standards of albumin. The FDA has also given approval for certain albumin products in recent years. Technological advancements such as recombinant HSA production are being researched across the U.S. and Canada to potentially reduce dependency on human plasma donations for albumin supply. The Asian albumin market is experiencing rapid expansion fueled by increasing healthcare expenditure and improving medical infrastructure in emerging countries demanding plasma-derived products for therapeutic purposes, including liver disease treatment, surgeries, and intensive care support. Europe is a potential contributor to the global albumin market, with an established consumption base and robust manufacturing capabilities. The use of albumin in Europe is primarily focused on critical care applications such as sepsis management, volume replacement therapies, and therapeutic plasma exchange procedures. The European Medicines Agency (EMA) regulates the production and distribution of albumin within the European Union (EU).

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Aadi Bioscience, Inc., Agilent Technologies, Inc., Akron Biotech, Atlantis Bioscience Pte Ltd., Avantor Inc., Baxter International Inc., Becton, Dickinson and Company, Bio Products Laboratory Ltd., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenix Inc. Pvt. Ltd., Biophyll GmbH, Biorbyt Ltd., Biowest SAS, Boston BioProducts Inc., Bristol-Myers Squibb Company, CENTURION PHARMA Ilac Sanayi ve Ticaret A.S., China Biologic Products Holdings, Inc. by Taibang Biologic Group, CSL Limited, Dem Ilac, F. Hoffmann-La Roche AG, GC Biopharma Corp., Glentham Life Sciences Limited, Grifols SA, InVitria, InVitroCare Inc., Kedrion S.p.A, Kraeber & Co. GmbH, Lazuline Biotech Private Limited, LGC Science Group Holdings Limited, Merck KGaA, Midas Pharma GmbH, Octapharma AG, Promega Corporation, Prospec-Tany Technogene Ltd., Rockland Immunochemicals Inc., Rocky Mountain Biologicals, LLC, Sartorius AG, Serion GmbH, SK Plasma, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and VitroScient.

Market Segmentation & Coverage

This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Source
  • Animal Sources
    • Bovine Serum Albumin
    • Human Serum Albumin
    • Ovalbumin

• Plant Sources

• Type
  • Non-Recombinant
  • Recombinant

• Application
  • Cosmetic Ingredient
  • Culture Media
  • Drug Delivery
  • Food Ingredient
  • Therapeutic
  • Vaccine Ingredient

• End User
  • Pharmaceutical & Biotechnology
  • Research Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Albumin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin Market?

3. What are the technology trends and regulatory frameworks in the Albumin Market?

4. What is the market share of the leading vendors in the Albumin Market?

5. Which modes and strategic moves are suitable for entering the Albumin Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
    • 5.1.1.2. Surging utilization of albumin as a food and cosmetic ingredient
  • 5.1.2. Restraints
    • 5.1.2.1. Potential of albumin to cause transmission of infections
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research activities regarding albumin nanoparticles
    • 5.1.3.2. Advancements in albumin production and purification methods
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations associated with albumin manufacturing and quality control
• 5.2. Market Segmentation Analysis
  • 5.2.1. Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.
  • 5.2.2. Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology
  • 5.2.3. Application: Rising focus on vaccine manufacturing and drug delivery applications
  • 5.2.4. End-User: Extensive end-users of the albumin in hospitals and blood banks
• 5.3. Market Trend Analysis
  • 5.3.1. Medical technology advancements supplemented with robust investment across the Americas
  • 5.3.2. Expanding production coupled with availability of safety regulations to monitor albumin products in APAC region
  • 5.3.3. Significant research activities and government regulatory framework in the EMEA region.
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis

6. Albumin Market, by Source

• 6.1. Introduction
• 6.2. Animal Sources
• 6.3. Plant Sources

7. Albumin Market, by Type

• 7.1. Introduction
• 7.2. Non-Recombinant
• 7.3. Recombinant

8. Albumin Market, by Application

• 8.1. Introduction
• 8.2. Cosmetic Ingredient
• 8.3. Culture Media
• 8.4. Drug Delivery
• 8.5. Food Ingredient
• 8.6. Therapeutic
• 8.7. Vaccine Ingredient

9. Albumin Market, by End User

• 9.1. Introduction
• 9.2. Pharmaceutical & Biotechnology
• 9.3. Research Institutes

10. Americas Albumin Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Albumin Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Albumin Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Grifols Completes Enrollment In Phase 3 Study Of Long-Term Albutein (Albumin-Human Injection) Therapy For Patients With Decompensated Cirrhosis
  • 13.3.2. Kedrion's Global Portfolio Expands To China To Supply Human Albumin
  • 13.3.3. GC Biopharma inks USD 90mn deal for blood products in Brazil
  • 13.3.4. Albumedix Enters into Collaboration Agreement with Cell and Gene Therapy Catapult
  • 13.3.5. Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine
  • 13.3.6. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
  • 13.3.7. SK Plasma to build USD 250m blood products plant in Indonesia
  • 13.3.8. Grifols Inaugurates New Albumin Plant At its Expanding Dublin Site
  • 13.3.9. Sartorius acquires Albumedix: A player in advanced therapies based on recombinant albumin
  • 13.3.10. Taibang Biologic Group Secures Equity Raising of USD 300 Million

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio